University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Bergische Landstrasse 2, 40629, Düsseldorf, Germany.
Eur Arch Psychiatry Clin Neurosci. 2020 Apr;270(3):311-324. doi: 10.1007/s00406-018-0949-4. Epub 2018 Oct 25.
Reports of limited clinical significance of attenuated psychotic symptoms before age 15/16 indicate an important role of neurodevelopment in the early detection of psychoses. Therefore, we examined if age also exerts an influence on the prevalence and clinical significance of the 14 cognitive and perceptive basic symptoms (BS) used in psychosis-risk criteria and conceptualized as the most direct self-experienced expression of neurobiological aberrations. A random representative general population sample of the Swiss canton Bern (N = 689, age 8-40 years, 06/2011-05/2014) was interviewed for BS, psychosocial functioning, and current mental disorder. BS were reported by 18% of participants, mainly cognitive BS (15%). In regression analyses, age affected perceptive and cognitive BS differently, indicating an age threshold for perceptive BS in late adolescence (around age 18) and for cognitive BS in young adulthood (early twenties)-with higher prevalence, but a lesser association with functional deficits and the presence of mental disorder in the below-threshold groups. Thereby, interaction effects between age and BS on functioning and mental disorder were commonly stronger than individual effects of age and BS. Indicating support of the proposed "substrate-closeness" of BS, differential age effects of perceptual and cognitive BS seem to follow normal brain maturation processes, in which they might occur as infrequent and temporary non-pathological disturbances. Their persistence or occurrence after conclusion of main brain maturation processes, however, might signify aberrant maturation or neurodegenerative processes. Thus, BS might provide important insight into the pathogenesis of psychosis and into differential neuroprotective or anti-inflammatory targets.
报告称,15/16 岁之前出现的精神病症状减轻具有有限的临床意义,这表明神经发育在精神病的早期检测中起着重要作用。因此,我们研究了年龄是否也会对精神病风险标准中使用的 14 种认知和知觉基本症状(BS)的患病率和临床意义产生影响,这些症状被概念化为神经生物学异常的最直接的自我体验表达。我们对瑞士伯尔尼州的一个随机代表性一般人群样本(N=689,年龄 8-40 岁,2011 年 6 月至 2014 年 5 月)进行了 BS、社会心理功能和当前精神障碍的访谈。18%的参与者报告了 BS,主要是认知 BS(15%)。在回归分析中,年龄对知觉和认知 BS 的影响不同,表明知觉 BS 的年龄阈值出现在青春期后期(约 18 岁),认知 BS 的年龄阈值出现在成年早期(二十出头)-在低于阈值的组中,BS 的患病率较高,但与功能缺陷和精神障碍的关联较小。因此,年龄和 BS 对功能和精神障碍的交互作用通常比年龄和 BS 的个体作用更强。这表明支持 BS 的“基质接近性”假设,知觉和认知 BS 的不同年龄效应似乎遵循正常的大脑成熟过程,在这个过程中,它们可能是罕见的和暂时的非病理性干扰。然而,在主要大脑成熟过程结束后,它们的持续存在或发生可能表明异常成熟或神经退行性过程。因此,BS 可能为精神病的发病机制以及不同的神经保护或抗炎靶点提供重要的见解。